First Perihelion of EUI on the Solar Orbiter mission

Context. The Extreme Ultraviolet Imager (EUI), onboard Solar Orbiter consists of three telescopes: the two High Resolution Imagers in EUV (HRIEUV) and in Lyman-{\alpha} (HRILya), and the Full Sun Imager (FSI). Solar Orbiter/EUI started its Nominal Mission Phase on 2021 November 27. Aims. EUI images from the largest scales in the extended corona off limb, down to the smallest features at the base of the corona and chromosphere. EUI is therefore a key instrument for the connection science that is at the heart of the Solar Orbiter mission science goals. Methods. The highest resolution on the Sun is achieved when Solar Orbiter passes through the perihelion part of its orbit. On 2022 March 26, Solar Orbiter reached for the first time a distance to the Sun close to 0.3 au. No other coronal EUV imager has been this close to the Sun. Results. We review the EUI data sets obtained during the period 2022 March-April, when Solar Orbiter quickly moved from alignment with the Earth (2022 March 6), to perihelion (2022 March 26), to quadrature with the Earth (2022 March 29). We highlight the first observational results in these unique data sets and we report on the in-flight instrument performance. Conclusions. EUI has obtained the highest resolution images ever of the solar corona in the quiet Sun and polar coronal holes. Several active regions were imaged at unprecedented cadences and sequence durations. We identify in this paper a broad range of features that require deeper studies. Both FSI and HRIEUV operate at design specifications but HRILya suffered from performance issues near perihelion. We conclude emphasising the EUI open data policy and encouraging further detailed analysis of the events highlighted in this paper

PIV à grande échelle appliquée sur la dispersion par explosif

International audienceBien que la dispersion atmosphérique soit largement étudiée dans la littérature,peu d’études s’intéressent à la dispersion par explosif, qui représente une source dynamique à haute vitesse et de courte durée. Ce savoir est essentiel pour développer et valider des outils permettant de prédire la dispersion après une explosion dans un milieu complexe. Le principal objectif de cette recherche est donc d’étudier la dispersion d’un polluant causée par une charge explosive. Une explosion en phase condensée générant la dispersion de particules solides est expérimentale-ment simulée par l’utilisation d’un détonateur RP80-EBW et d’une poudre de talc dont la granulométrie moyenne est de 7.8 μm de diamètre. La dispersion se fait en champ libre dans une soufflerie subsonique où une couche atmosphérique urbaine contrôlée est reproduite. La dispersion est étudiée à l’aide d’une caméra rapide travaillant à une fréquence allant de 2000 Hz à 10869 Hz. L’évolution temporelle des champs de vitesse lors de la dispersion est obtenue par vélocimétrie par imagerie de particules à grande échelle (LS-PIV). Deux types d’éclairage sont utilisés : le premier éclairage est obtenu à l’aide d’une lampe placée au-dessus de la caméra rapide, donnant une vision globale de la dispersion, le second est effectué à l’aide d’une tranche laser en régime continu, générant une vision 2D.Les deux types de visualisation sont comparés ; leurs similitudes et différences sont présentés. Deux méthodes sont utilisées pour l’analyse LS-PIV. Les points forts et les points faibles de ces deux méthodes sont soulignés. Enfin, les propriétés nécessaires qu’une image doit posséder pour obtenir une analyse par corrélation croisée de qualité sont comparées entre l’analyse PIV classique et l’analyse LS-PIV.La dispersion en champ libre est étudiée pour différentes vitesses de vent (de 0 m/sà 5 m/s). L’évolution temporelle des champs de vitesse permet d’étudier l’effet du vent sur la dispersion

Extreme-UV quiet Sun brightenings observed by the Solar Orbiter/EUI

peer reviewedContext. The heating of the solar corona by small heating events requires an increasing number of such events at progressively smaller scales, with the bulk of the heating occurring at scales that are currently unresolved. Aims. The goal of this work is to study the smallest brightening events observed in the extreme-UV quiet Sun. Methods. We used commissioning data taken by the Extreme Ultraviolet Imager (EUI) on board the recently launched Solar Orbiter mission. On 30 May 2020, the EUI was situated at 0.556 AU from the Sun. Its High Resolution EUV telescope (HRIEUV, 17.4 nm passband) reached an exceptionally high two-pixel spatial resolution of 400 km. The size and duration of small-scale structures was determined by the HRIEUV data, while their height was estimated from triangulation with simultaneous images from the Atmospheric Imaging Assembly (AIA) on board the Solar Dynamics Observatory mission. This is the first stereoscopy of small-scale brightenings at high resolution. Results. We observed small localised brightenings, also known as 'campfires', in a quiet Sun region with length scales between 400 km and 4000 km and durations between 10 s and 200 s. The smallest and weakest of these HRIEUV brightenings have not been previously observed. Simultaneous observations from the EUI High-resolution Lyman-α telescope (HRILya) do not show localised brightening events, but the locations of the HRIEUV events clearly correspond to the chromospheric network. Comparisons with simultaneous AIA images shows that most events can also be identified in the 17.1 nm, 19.3 nm, 21.1 nm, and 30.4 nm pass-bands of AIA, although they appear weaker and blurred. Our differential emission measure analysis indicated coronal temperatures peaking at log T ≈ 6.1 - 6.15. We determined the height for a few of these campfires to be between 1000 and 5000 km above the photosphere. Conclusions. We find that 'campfires' are mostly coronal in nature and rooted in the magnetic flux concentrations of the chromospheric network. We interpret these events as a new extension to the flare-microflare-nanoflare family. Given their low height, the EUI 'campfires' could stand as a new element of the fine structure of the transition region-low corona, that is, as apexes of small-scale loops that undergo internal heating all the way up to coronal temperatures

Stereoscopy of extreme UV quiet Sun brightenings observed by Solar Orbiter/EUI

peer reviewedContext. The three-dimensional fine structure of the solar atmosphere is still not fully understood as most of the available observations are taken from a single vantage point. Aims. The goal of the paper is to study the three-dimensional distribution of the small-scale brightening events ("campfires") discovered in the extreme-UV quiet Sun by the Extreme Ultraviolet Imager (EUI) aboard Solar Orbiter. Methods. We used a first commissioning data set acquired by the EUI's High Resolution EUV telescope on 30 May 2020 in the 174 Å passband and we combined it with simultaneous data taken by the Atmospheric Imaging Assembly (AIA) aboard the Solar Dynamics Observatory in a similar 171 Å passband. The two-pixel spatial resolution of the two telescopes is 400 km and 880 km, respectively, which is sufficient to identify the campfires in both data sets. The two spacecraft had an angular separation of around 31.5° (essentially in heliographic longitude), which allowed for the three-dimensional reconstruction of the campfire position. These observations represent the first time that stereoscopy was achieved for brightenings at such a small scale. Manual and automatic triangulation methods were used to characterize the campfire data. Results. The height of the campfires is located between 1000 km and 5000 km above the photosphere and we find a good agreement between the manual and automatic methods. The internal structure of campfires is mostly unresolved by AIA; however, for a particularly large campfire, we were able to triangulate a few pixels, which are all in a narrow range between 2500 and 4500 km. Conclusions. We conclude that the low height of EUI campfires suggests that they belong to the previously unresolved fine structure of the transition region and low corona of the quiet Sun. They are probably apexes of small-scale dynamic loops heated internally to coronal temperatures. This work demonstrates that high-resolution stereoscopy of structures in the solar atmosphere has become feasible

First perihelion of EUI on the Solar Orbiter mission

International audienceContext. The Extreme Ultraviolet Imager (EUI) on board Solar Orbiter consists of three telescopes: the two High Resolution Imagers, in EUV (HRIEUV) and in Lyman-α (HRILya), and the Full Sun Imager (FSI). Solar Orbiter/EUI started its Nominal Mission Phase on 2021 November 27. Aims. Our aim is to present the EUI images from the largest scales in the extended corona off-limb down to the smallest features at the base of the corona and chromosphere. EUI is therefore a key instrument for the connection science that is at the heart of the Solar Orbiter mission science goals. Methods. The highest resolution on the Sun is achieved when Solar Orbiter passes through the perihelion part of its orbit. On 2022 March 26, Solar Orbiter reached, for the first time, a distance to the Sun close to 0.3 au. No other coronal EUV imager has been this close to the Sun. Results. We review the EUI data sets obtained during the period 2022 March- April, when Solar Orbiter quickly moved from alignment with the Earth (2022 March 6), to perihelion (2022 March 26), to quadrature with the Earth (2022 March 29). We highlight the first observational results in these unique data sets and we report on the in-flight instrument performance. Conclusions. EUI has obtained the highest resolution images ever of the solar corona in the quiet Sun and polar coronal holes. Several active regions were imaged at unprecedented cadences and sequence durations. We identify in this paper a broad range of features that require deeper studies. Both FSI and HRIEUV operated at design specifications, but HRILya suffered from performance issues near perihelion. We conclude by emphasizing the EUI open data policy and encouraging further detailed analysis of the events highlighted in this paper

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

International audienceBackground: Various observations have suggested that the course of COVID-19 might be less favourable in patients with inflammatory rheumatic and musculoskeletal diseases receiving rituximab compared with those not receiving rituximab. We aimed to investigate whether treatment with rituximab is associated with severe COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases.Methods: In this cohort study, we analysed data from the French RMD COVID-19 cohort, which included patients aged 18 years or older with inflammatory rheumatic and musculoskeletal diseases and highly suspected or confirmed COVID-19. The primary endpoint was the severity of COVID-19 in patients treated with rituximab (rituximab group) compared with patients who did not receive rituximab (no rituximab group). Severe disease was defined as that requiring admission to an intensive care unit or leading to death. Secondary objectives were to analyse deaths and duration of hospital stay. The inverse probability of treatment weighting propensity score method was used to adjust for potential confounding factors (age, sex, arterial hypertension, diabetes, smoking status, body-mass index, interstitial lung disease, cardiovascular diseases, cancer, corticosteroid use, chronic renal failure, and the underlying disease [rheumatoid arthritis vs others]). Odds ratios and hazard ratios and their 95% CIs were calculated as effect size, by dividing the two population mean differences by their SD. This study is registered with ClinicalTrials.gov, NCT04353609.Findings: Between April 15, 2020, and Nov 20, 2020, data were collected for 1090 patients (mean age 55·2 years [SD 16·4]); 734 (67%) were female and 356 (33%) were male. Of the 1090 patients, 137 (13%) developed severe COVID-19 and 89 (8%) died. After adjusting for potential confounding factors, severe disease was observed more frequently (effect size 3·26, 95% CI 1·66-6·40, p=0·0006) and the duration of hospital stay was markedly longer (0·62, 0·46-0·85, p=0·0024) in the 63 patients in the rituximab group than in the 1027 patients in the no rituximab group. 13 (21%) of 63 patients in the rituximab group died compared with 76 (7%) of 1027 patients in the no rituximab group, but the adjusted risk of death was not significantly increased in the rituximab group (effect size 1·32, 95% CI 0·55-3·19, p=0·53).Interpretation: Rituximab therapy is associated with more severe COVID-19. Rituximab will have to be prescribed with particular caution in patients with inflammatory rheumatic and musculoskeletal diseases

Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

International audienceObjectives: There is little known about the impact of SARS-CoV-2 on patients with inflammatory rheumatic and musculoskeletal diseases (iRMD). We examined epidemiological characteristics associated with severe disease, then with death. We also compared mortality between patients hospitalised for COVID-19 with and without iRMD.Methods: Individuals with suspected iRMD-COVID-19 were included in this French cohort. Logistic regression models adjusted for age and sex were used to estimate adjusted ORs and 95% CIs of severe COVID-19. The most significant clinically relevant factors were analysed by multivariable penalised logistic regression models, using a forward selection method. The death rate of hospitalised patients with iRMD-COVID-19 (moderate-severe) was compared with a subset of patients with non-iRMD-COVID-19 from a French hospital matched for age, sex, and comorbidities.Results: Of 694 adults, 438 (63%) developed mild (not hospitalised), 169 (24%) moderate (hospitalised out of the intensive care unit (ICU) and 87 (13%) severe (patients in ICU/deceased) disease. In multivariable imputed analyses, the variables associated with severe infection were age (OR=1.08, 95% CI: 1.05-1.10), female gender (OR=0.45, 95% CI: 0.25-0.80), body mass index (OR=1.07, 95% CI: 1.02-1.12), hypertension (OR=1.86, 95% CI: 1.01-3.42), and use of corticosteroids (OR=1.97, 95% CI: 1.09-3.54), mycophenolate mofetil (OR=6.6, 95% CI: 1.47-29.62) and rituximab (OR=4.21, 95% CI: 1.61-10.98). Fifty-eight patients died (8% (total) and 23% (hospitalised)). Compared with 175 matched hospitalised patients with non-iRMD-COVID-19, the OR of mortality associated with hospitalised patients with iRMD-COVID-19 was 1.45 (95% CI: 0.87-2.42) (n=175 each group).Conclusions: In the French RMD COVID-19 cohort, as already identified in the general population, older age, male gender, obesity, and hypertension were found to be associated with severe COVID-19. Patients with iRMD on corticosteroids, but not methotrexate, or tumour necrosis factor alpha and interleukin-6 inhibitors, should be considered as more likely to develop severe COVID-19. Unlike common comorbidities such as obesity, and cardiovascular or lung diseases, the risk of death is not significantly increased in patients with iRMD

Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

International audienceObjectives: There is little known about the impact of SARS-CoV-2 on patients with inflammatory rheumatic and musculoskeletal diseases (iRMD). We examined epidemiological characteristics associated with severe disease, then with death. We also compared mortality between patients hospitalised for COVID-19 with and without iRMD.Methods: Individuals with suspected iRMD-COVID-19 were included in this French cohort. Logistic regression models adjusted for age and sex were used to estimate adjusted ORs and 95% CIs of severe COVID-19. The most significant clinically relevant factors were analysed by multivariable penalised logistic regression models, using a forward selection method. The death rate of hospitalised patients with iRMD-COVID-19 (moderate-severe) was compared with a subset of patients with non-iRMD-COVID-19 from a French hospital matched for age, sex, and comorbidities.Results: Of 694 adults, 438 (63%) developed mild (not hospitalised), 169 (24%) moderate (hospitalised out of the intensive care unit (ICU) and 87 (13%) severe (patients in ICU/deceased) disease. In multivariable imputed analyses, the variables associated with severe infection were age (OR=1.08, 95% CI: 1.05-1.10), female gender (OR=0.45, 95% CI: 0.25-0.80), body mass index (OR=1.07, 95% CI: 1.02-1.12), hypertension (OR=1.86, 95% CI: 1.01-3.42), and use of corticosteroids (OR=1.97, 95% CI: 1.09-3.54), mycophenolate mofetil (OR=6.6, 95% CI: 1.47-29.62) and rituximab (OR=4.21, 95% CI: 1.61-10.98). Fifty-eight patients died (8% (total) and 23% (hospitalised)). Compared with 175 matched hospitalised patients with non-iRMD-COVID-19, the OR of mortality associated with hospitalised patients with iRMD-COVID-19 was 1.45 (95% CI: 0.87-2.42) (n=175 each group).Conclusions: In the French RMD COVID-19 cohort, as already identified in the general population, older age, male gender, obesity, and hypertension were found to be associated with severe COVID-19. Patients with iRMD on corticosteroids, but not methotrexate, or tumour necrosis factor alpha and interleukin-6 inhibitors, should be considered as more likely to develop severe COVID-19. Unlike common comorbidities such as obesity, and cardiovascular or lung diseases, the risk of death is not significantly increased in patients with iRMD

The Solar Orbiter EUI instrument: The Extreme Ultraviolet Imager

Context. The Extreme Ultraviolet Imager (EUI) is part of the remote sensing instrument package of the ESA/NASA Solar Orbiter mission that will explore the inner heliosphere and observe the Sun from vantage points close to the Sun and out of the ecliptic. Solar Orbiter will advance the "connection science" between solar activity and the heliosphere. Aims: With EUI we aim to improve our understanding of the structure and dynamics of the solar atmosphere, globally as well as at high resolution, and from high solar latitude perspectives. Methods: The EUI consists of three telescopes, the Full Sun Imager and two High Resolution Imagers, which are optimised to image in Lyman-α and EUV (17.4 nm, 30.4 nm) to provide a coverage from chromosphere up to corona. The EUI is designed to cope with the strong constraints imposed by the Solar Orbiter mission characteristics. Limited telemetry availability is compensated by state-of-the-art image compression, onboard image processing, and event selection. The imposed power limitations and potentially harsh radiation environment necessitate the use of novel CMOS sensors. As the unobstructed field of view of the telescopes needs to protrude through the spacecraft's heat shield, the apertures have been kept as small as possible, without compromising optical performance. This led to a systematic effort to optimise the throughput of every optical element and the reduction of noise levels in the sensor. Results: In this paper we review the design of the two elements of the EUI instrument: the Optical Bench System and the Common Electronic Box. Particular attention is also given to the onboard software, the intended operations, the ground software, and the foreseen data products. Conclusions: The EUI will bring unique science opportunities thanks to its specific design, its viewpoint, and to the planned synergies with the other Solar Orbiter instruments. In particular, we highlight science opportunities brought by the out-of-ecliptic vantage point of the solar poles, the high-resolution imaging of the high chromosphere and corona, and the connection to the outer corona as observed by coronagraphs